NTRA Q3 2018 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q3 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$65M+15.2% YoY

Gross Profit

$24M36.2% margin

Operating Income

-$27M-41.6% margin

Net Income

-$30M-45.4% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$277M

Total Liabilities

$221M

Stockholders' Equity

$57M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$57M	+15.2%
Gross Profit	$24M	$22M	+7.1%
Operating Income	-$27M	-$25M	-8.5%
Net Income	-$30M	-$27M	-9.2%

Revenue Segments

Product

$63M48%

Panorama Nipt

$36M28%

Hcs

$24M18%

Other Genetic Tests

$3M2%

Licensing And Other

$3M2%

Other Licensing And Other

$2M1%

Constellation

$1M1%

Geographic Segments

U

$59M90%

E M E A

$4M6%

Other Geographic Areas

$2M3%

Americas Excluding Us

$932,0001%